Cargando…
Lysosomal Storage Disorders: Clinical, Biochemical and molecular profile from Rare disease centre, India
INTRODUCTION: Lysosomal storage disorders (LSDs) are a heterogeneous group of large molecule inborn errors of metabolism, rather commonly seen by clinician. OBJECTIVES: This study aims to highlight the more common type of LSDs, their frequency, clinical spectrum and outcome from Rare disease centre...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8680872/ https://www.ncbi.nlm.nih.gov/pubmed/35002125 http://dx.doi.org/10.4103/aian.AIAN_1009_20 |
_version_ | 1784616847853748224 |
---|---|
author | Goyal, Manisha Gupta, Ashok |
author_facet | Goyal, Manisha Gupta, Ashok |
author_sort | Goyal, Manisha |
collection | PubMed |
description | INTRODUCTION: Lysosomal storage disorders (LSDs) are a heterogeneous group of large molecule inborn errors of metabolism, rather commonly seen by clinician. OBJECTIVES: This study aims to highlight the more common type of LSDs, their frequency, clinical spectrum and outcome from Rare disease centre in Rajasthan. METHODS: The retrospective data were collected including clinical profile, investigations, screening test and enzyme analysis results. All outcomes were recorded from follow-up clinic. RESULTS: This cohort comprised 65 children with different type of LSDs including 54 males and 11 females. The average age of presentation of the LSD patients was 3.5 years (range 6 months to 13 years). Gaucher disease was the most commonly found LSD (46.1%) followed by mucopolysaccharidosis (35.3%). Common presentations among GD patients were anemia, thrombocytopenia, and abdominal distension due to splenohepatomegaly/hepatomegaly. Among MPS Disorder, MPS type 2 (Hunter syndrome) was the most common (39.1%), followed by MPS type 1(Hurler syndrome) (30%) and MPS type IVA (Morquio syndrome) (17.3%). Non GD non MPS group comprised most commonly of GM1 gangliosidosis followed by pompe disease, Metachromatic Leucodystrophy, Mucolipidosis type II (I cell disease), and Sandhoff disease. CONCLUSIONS: LSDs comprises an important group of genetic metabolic disorders. Among these GD are the most common, followed by MPS. |
format | Online Article Text |
id | pubmed-8680872 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-86808722022-01-06 Lysosomal Storage Disorders: Clinical, Biochemical and molecular profile from Rare disease centre, India Goyal, Manisha Gupta, Ashok Ann Indian Acad Neurol Original Article INTRODUCTION: Lysosomal storage disorders (LSDs) are a heterogeneous group of large molecule inborn errors of metabolism, rather commonly seen by clinician. OBJECTIVES: This study aims to highlight the more common type of LSDs, their frequency, clinical spectrum and outcome from Rare disease centre in Rajasthan. METHODS: The retrospective data were collected including clinical profile, investigations, screening test and enzyme analysis results. All outcomes were recorded from follow-up clinic. RESULTS: This cohort comprised 65 children with different type of LSDs including 54 males and 11 females. The average age of presentation of the LSD patients was 3.5 years (range 6 months to 13 years). Gaucher disease was the most commonly found LSD (46.1%) followed by mucopolysaccharidosis (35.3%). Common presentations among GD patients were anemia, thrombocytopenia, and abdominal distension due to splenohepatomegaly/hepatomegaly. Among MPS Disorder, MPS type 2 (Hunter syndrome) was the most common (39.1%), followed by MPS type 1(Hurler syndrome) (30%) and MPS type IVA (Morquio syndrome) (17.3%). Non GD non MPS group comprised most commonly of GM1 gangliosidosis followed by pompe disease, Metachromatic Leucodystrophy, Mucolipidosis type II (I cell disease), and Sandhoff disease. CONCLUSIONS: LSDs comprises an important group of genetic metabolic disorders. Among these GD are the most common, followed by MPS. Wolters Kluwer - Medknow 2021 2021-03-27 /pmc/articles/PMC8680872/ /pubmed/35002125 http://dx.doi.org/10.4103/aian.AIAN_1009_20 Text en Copyright: © 2006 - 2021 Annals of Indian Academy of Neurology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Goyal, Manisha Gupta, Ashok Lysosomal Storage Disorders: Clinical, Biochemical and molecular profile from Rare disease centre, India |
title | Lysosomal Storage Disorders: Clinical, Biochemical and molecular profile from Rare disease centre, India |
title_full | Lysosomal Storage Disorders: Clinical, Biochemical and molecular profile from Rare disease centre, India |
title_fullStr | Lysosomal Storage Disorders: Clinical, Biochemical and molecular profile from Rare disease centre, India |
title_full_unstemmed | Lysosomal Storage Disorders: Clinical, Biochemical and molecular profile from Rare disease centre, India |
title_short | Lysosomal Storage Disorders: Clinical, Biochemical and molecular profile from Rare disease centre, India |
title_sort | lysosomal storage disorders: clinical, biochemical and molecular profile from rare disease centre, india |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8680872/ https://www.ncbi.nlm.nih.gov/pubmed/35002125 http://dx.doi.org/10.4103/aian.AIAN_1009_20 |
work_keys_str_mv | AT goyalmanisha lysosomalstoragedisordersclinicalbiochemicalandmolecularprofilefromrarediseasecentreindia AT guptaashok lysosomalstoragedisordersclinicalbiochemicalandmolecularprofilefromrarediseasecentreindia |